The Human Cancer PrimaCell™ 5: Cervical Tumor Cells is for rapid (7-10 days) isolation and growth of human cervical tumor cells from human cervical tumor tissues. This system features an optimal condition of tissue dissociation system, Cancer OptiTDS™ that yields 6-8 times of single cells more than most of the tissue dissociation protocols published in the literature. In addition, this system ensures a high viability of the target cells with improved gradient contained in the culture medium.

Human Cancer PrimaCell™ 5 System (Cat No. 2-96028):
Human Cancer PrimaCell™ 5: Cervical Tumor Cells Protocols
Human Cancer Tissue Preparation Buffer 5: Cervical Tumor Cells
Human Cancer OptiTDS™ 5: Tissue Dissociation System
Human Cancer PrimaCell™ 5: Cervical Tumor Cells Growth Medium
Human Cancer PrimaCell™ 5: Cervical Tumor Cells Growth Supplements with Serum (for 500 ml medium)

References:

[1] Magaldi TG, Almstead LL, Bellone S, Prevatt EG, Santin AD, DiMaio D. Primary human cervical carcinoma cells require human papillomavirus E6 and E7 expression for ongoing proliferation. Virology. 2012 Jan 5;422(1):114-24. Epub 2011 Nov 5.
[2] Feng D, Peng C, Li C, Zhou Y, Li M, Ling B, Wei H, Tian Z. Identification and characterization of cancer stem-like cells from primary carcinoma of the cervix uteri. Oncol Rep. 2009 Nov;22(5):1129-34.
[3] Beerens E, Van Renterghem L, Praet M, Sturtewagen Y, Weyers S, Temmerman M, Depypere H, Claeys P, Cuvelier CA. Human papillomavirus DNA detection in women with primary abnormal cytology of the cervix: prevalence and distribution of HPV genotypes. Cytopathology. 2005 Aug;16(4):199-205.